Interleukin-6 Inhibitors Improve Overall Survival Outcomes in Severe COVID-19
Investigators compared treatment with interleukin-6 inhibitors with standard of care among patients hospitalized with COVID-19 infection.
Investigators compared treatment with interleukin-6 inhibitors with standard of care among patients hospitalized with COVID-19 infection.
Investigators conducted a study to assess whether proteomic measurements accurately predict outcomes among patients with severe COVID-19 infection.
Investigators conducted a study that compared the risk for infection from the dispersion of respiratory droplets from a person walking downstairs vs upstairs.
Researchers conducted a study to compare the effects of intravenous vs oral antibiotics therapy in patients with a pulmonary infection caused by Pseudomonas aeruginosa secondary to cystic fibrosis.
Investigators conducted a study to determine the effect of cigarette smoking in patients with recurrent aphthous stomatitis.
Investigators conducted a study to assess the efficacy and safety of aspirin therapy in patients hospitalized with COVID-19.
Investigators conducted a study to determine whether positive expiratory pressure flute self-care decreases the risk for respiratory symptoms in adults recently diagnosed with SARS-CoV-2 infection.
Researchers conducted a study to determine whether molecular biomarkers of tubular injury measured on hospital admission are a significant predictor of acute kidney injury in patients with SARS-CoV-2 infection.
Researchers conducted a study to assess the clinical efficacy, safety, and tolerability of Paxlovid (PF-07321332/ritonavir), an oral SARS-CoV-2 Mpro inhibitor candidate for the treatment of COVID-19.
Researchers conducted a study to determine whether treatment with sotrovimab decreases the risk for severe disease progression among high-risk patients with mild-to-moderate COVID-19.